Consumer-grade 3D printing is good for prototyping and making relatively soft plastic stuff. If you wanna make tough things, though, it’s really hard to beat the strength of metal. [Shake the Future] ...

Last season, the Toronto Blue Jays had three pitchers who made at least 30 starts in their near-Cinderella story of a run: Kevin Gausman, Chris Bassitt, and José Berrios. Only their Opening Day ...

PORT ST. LUCIE, Fla. — The Houston Astros’ pitching plans to begin the season are starting to take shape. Houston will open with a five-man starting rotation, manager Joe Espada said Saturday. Astros ...

A federal judge on Monday temporarily blocked federal health officials from cutting the number of vaccines recommended for every child, and said U.S. Health Secretary Robert F. Kennedy Jr. likely ...

Celebrities are dropping weight left and right, leading to Ozempic rumors. For Oprah Winfrey, those rumors are true — and her transformation has been astounding. Trump's current average approval ...

OpenAI announced a landmark funding round and strategic alliances on February 27, 2026, aimed at expanding the reach of artificial intelligence across consumers, developers, and enterprises while ...

AI agents can take on some tasks, yet challenges can arise when companies link them together. One longtime tech exec says that's why, for now, autonomous AI remains aspirational. Both leaders and ...

In identity security, complexity is a given. Buying cycles stretch across months, multiple stakeholders shape every decision, and marketing teams are expected to prove impact with speed and clarity.

The CRAFT method uses widely available materials and inexpensive commercial 3D printers. Using an affordable 3D printer and the CRAFT method, researchers created a model human hand from a single ...

Large-scale business transformations are among the most complex challenges leaders face. They involve reshaping operating models, rethinking technology foundations, redefining culture, and aligning ...

Novavax secures a non-exclusive licensing deal with Pfizer, validating Matrix-M's platform value and shifting NVAX toward a technology provider model. NVAX receives $30M upfront, a potential $500M in ...